222 related articles for article (PubMed ID: 20509975)
1. Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin.
Shiau AL; Teo ML; Chen SY; Wang CR; Hsieh JL; Chang MY; Chang CJ; Chao J; Chao L; Wu CL; Lee CH
BMC Cancer; 2010 May; 10():245. PubMed ID: 20509975
[TBL] [Abstract][Full Text] [Related]
2. AAV-mediated gene transfer of human pigment epithelium-derived factor inhibits Lewis lung carcinoma growth in mice.
He SS; Shi HS; Yin T; Li YX; Luo ST; Wu QJ; Lu L; Wei YQ; Yang L
Oncol Rep; 2012 Apr; 27(4):1142-8. PubMed ID: 22218393
[TBL] [Abstract][Full Text] [Related]
3. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
[TBL] [Abstract][Full Text] [Related]
4. Kallistatin is a new inhibitor of angiogenesis and tumor growth.
Miao RQ; Agata J; Chao L; Chao J
Blood; 2002 Nov; 100(9):3245-52. PubMed ID: 12384424
[TBL] [Abstract][Full Text] [Related]
5. Kallistatin Suppresses Cell Proliferation and Invasion and Promotes Apoptosis in Cervical Cancer Through Blocking NF-κB Signaling.
Wang T; Shi F; Wang J; Liu Z; Su J
Oncol Res; 2017 May; 25(5):809-817. PubMed ID: 27983915
[TBL] [Abstract][Full Text] [Related]
6. Reduction of metastatic and angiogenic potency of malignant cancer by Eupatorium fortunei via suppression of MMP-9 activity and VEGF production.
Kim A; Im M; Yim NH; Ma JY
Sci Rep; 2014 Nov; 4():6994. PubMed ID: 25385232
[TBL] [Abstract][Full Text] [Related]
7. Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation.
Ma C; Yin H; Zhong J; Zhang Y; Luo C; Che D; Fang Z; Li L; Qin S; Liang J; Qi W; Yang Z; Zhou T; Ma J; Yang X; Gao G
Int J Oncol; 2017 Jun; 50(6):2000-2010. PubMed ID: 28440474
[TBL] [Abstract][Full Text] [Related]
8. Kallistatin, a novel anti-angiogenesis agent, inhibits angiogenesis via inhibition of the NF-κB signaling pathway.
Huang KF; Huang XP; Xiao GQ; Yang HY; Lin JS; Diao Y
Biomed Pharmacother; 2014 May; 68(4):455-61. PubMed ID: 24721321
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistatin.
Diao Y; Ma J; Xiao WD; Luo J; Li XY; Chu KW; Fung P; Habib N; Farzaneh F; Xu RA
World J Gastroenterol; 2007 Sep; 13(34):4615-9. PubMed ID: 17729417
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Adeno-associated Virus 9-mediated Expression of Kallistatin Suppresses Lung Tumor Growth in Mice.
Qu W; Zhao J; Wu Y; Xu R; Liu S
Curr Gene Ther; 2021; 21(1):72-80. PubMed ID: 33183200
[TBL] [Abstract][Full Text] [Related]
11. Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice.
Agrawal V; Maharjan S; Kim K; Kim NJ; Son J; Lee K; Choi HJ; Rho SS; Ahn S; Won MH; Ha SJ; Koh GY; Kim YM; Suh YG; Kwon YG
Oncotarget; 2014 May; 5(9):2761-77. PubMed ID: 24811731
[TBL] [Abstract][Full Text] [Related]
12. [Plasmid-mediated expression of kallistatin and its biological activity in lung cancer related cells].
Wang NQ; Zou J; Diao Y
Yao Xue Xue Bao; 2013 Mar; 48(3):359-65. PubMed ID: 23724648
[TBL] [Abstract][Full Text] [Related]
13. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
Zhu Z; Hou Q; Guo H
Exp Cell Res; 2020 Dec; 397(1):112311. PubMed ID: 32991874
[TBL] [Abstract][Full Text] [Related]
14. Enhanced efficacy of combination therapy with adeno‑associated virus-delivered pigment epithelium-derived factor and cisplatin in a mouse model of Lewis lung carcinoma.
He SS; Wu QJ; Gong CY; Luo ST; Zhang S; Li M; Lu L; Wei YQ; Yang L
Mol Med Rep; 2014 Jun; 9(6):2069-76. PubMed ID: 24714917
[TBL] [Abstract][Full Text] [Related]
15. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.
Carneiro-Lobo TC; Scalabrini LC; Magalhães LDS; Cardeal LB; Rodrigues FS; Dos Santos EO; Baldwin AS; Levantini E; Giordano RJ; Bassères DS
Lung Cancer; 2019 Apr; 130():169-178. PubMed ID: 30885340
[TBL] [Abstract][Full Text] [Related]
16. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
17. Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation.
Yin H; Gao L; Shen B; Chao L; Chao J
Hypertension; 2010 Aug; 56(2):260-7. PubMed ID: 20566960
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
Chia JS; Du JL; Hsu WB; Sun A; Chiang CP; Wang WB
BMC Cancer; 2010 Apr; 10():175. PubMed ID: 20429953
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of 2-oxoglutarate through inhibition of angiogenesis in a murine tumor model.
Matsumoto K; Obara N; Ema M; Horie M; Naka A; Takahashi S; Imagawa S
Cancer Sci; 2009 Sep; 100(9):1639-47. PubMed ID: 19575748
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer of inhibitor kappaB in human lung cancer cell line NCI-H460 inhibits tumorigenesis and angiogenesis in vivo.
Ni J; Takayama K; Inoshima N; Uchino J; Harada A; Minami T; Harada T; Zhou C; Nakanishi Y
Anticancer Res; 2005; 25(1A):69-77. PubMed ID: 15816521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]